These effects, together with a preceding report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 assist the concept of targeting ACKR3 as a novel approach to modulate the opioid system, which could open up new therapeutic avenues for opioid-associated disorders. We independently analysis, evaluate, and https://ammonf538bkl1.wannawiki.com/user